Regulatory & Legal

In a bold strategic shift, private jet operator Volato is entering the national security-focused critical minerals sector, guided by a seasoned financier.

As 374Water pushes its waste-destroying tech to market, a new board member with deep financial expertise and a history as a long-term investor joins.

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.

After a 600%+ stock surge and an abrupt SEC trading halt, Charming Medical is now facing class action lawsuits alleging a social media manipulation scheme.

Establishment Labs has submitted its innovative Motiva implants for FDA approval in reconstruction, promising a new era for post-mastectomy care.

Anfield Energy appoints financial expert Lubica Niemann as CFO, signaling a strategic move to manage NASDAQ compliance and its ambitious US uranium production goals.

A new study reveals a seismic shift in why Americans move, with family ties and smaller cities pulling people away from traditional economic hubs.

A new investment vehicle aims to solve green hydrogen's biggest funding hurdle, launching with a key industrial decarbonization project in Spain.

DHT Holdings sells two older tankers for $101.6M, securing a major cash injection. The move highlights a strategy of fleet renewal and shareholder value.

Valens Semiconductor's 2024 ESG report details major drops in emissions and energy use, but how do these gains stack up in the high-stakes tech world?

Adlai Nortye licenses its promising pan-RAS cancer inhibitor to ASK Pharm for Greater China in a deal valued at up to $230 million.

For the 13th consecutive year, Karmanos Cancer Institute is named a top US hospital, a distinction driven by patient safety and women's care preferences.

Saving for a home is faster than in 2022, but a new report reveals a stark divide, with some facing a 30-year wait while others can buy in under two.

Biomaterials firm Bolt Projects posts huge revenue gains and raises 2026 guidance, but a looming Nasdaq delisting threat casts a shadow on its future.

An FDA setback for its new mastitis drug prompts ImmuCell to double down on its profitable calf health franchise, First Defense®, in a major strategic shift.

The cardiac device innovator adds seasoned sales and operations executives to prepare its novel cryoablation technology for the global market.

Croatian firm Orqa is building a global network to produce one million drones annually, challenging market leaders and securing allied defense supply chains.

Global asset manager Patria Investments creates a new COO role and shuffles its finance leadership in a strategic move to scale operations globally.

Launching this Christmas, 'The Resurrection Coin' blends faith with Web3 to fund a new film, but faces scrutiny over its regulatory claims.

Securities processors have filed a plan to extend trading to nearly 24 hours a day, a move set to transform Wall Street but posing huge tech hurdles.